bioAffinity Technologies, Inc. - Common Stock
bioAffinity Technologies, Inc. - Common Stock
Share · US09076W1099 · BIAF (XNAS)
Overview
Analyst Grade Summary
gauge-img
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
0
1
0
0
No Price
19.12.2025 22:14
Current Prices from bioAffinity Technologies, Inc. - Common Stock
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
BIAF
USD
19.12.2025 22:14
1,24 USD
0,01 USD
+1,06 %
Share Float & Liquidity
Free Float 96,62 %
Shares Float 4,35 M
Shares Outstanding 4,5 M
Company Profile for bioAffinity Technologies, Inc. - Common Stock Share
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
AI Analysis of bioAffinity Technologies, Inc. - Common Stock
Click any analysis below to get instant AI insights from finAgent

Company Data

Name bioAffinity Technologies, Inc. - Common Stock
Company bioAffinity Technologies, Inc.
Symbol BIAF
Website https://www.bioaffinitytech.com
Primary Exchange XNAS NASDAQ
ISIN US09076W1099
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Maria Zannes
Country United States of America
Currency USD
Employees 0,1 T
Address 22211 West Interstate 10, 78257 San Antonio
IPO Date 2022-09-01

Stock Splits

Date Split
19.09.2025 1:30

Ticker Symbols

Name Symbol
NASDAQ BIAF
More Shares
Investors who hold bioAffinity Technologies, Inc. - Common Stock also have the following shares in their portfolio:
LUCID GROUP 21/26 CV
LUCID GROUP 21/26 CV Bond
QIFU TECHNOL 25/30 CV
QIFU TECHNOL 25/30 CV Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025